Search research articles
Contact Us
Filters
Showing results (191-200 of 249) with videos related to
Page
of 25
Sort By:
Journal of Lipid Research
|
November 13, 2008
PLTP activity is a risk factor for subsequent cardiovascular events in CAD patients under statin therapy: the AtheroGene study
Axel Schlitt, Stefan Blankenberg, Christoph Bickel, et al.
International Journal of Cardiology
|
May 13, 2015
Prognostic impact of established and novel renal function biomarkers in myocardial infarction with cardiogenic shock: A biomarker substudy of the IABP-SHOCK II-trial
Georg Fuernau, Christian Poenisch, Ingo Eitel, et al.
Biomedizinische Technik. Biomedical Engineering
|
August 19, 2006
Analysis of complex physiological systems by information flow: a time scale-specific complexity assessment
Dirk Hoyer, Birgit Frank, Bernd Pompe, et al.
American Journal of Nephrology
|
February 20, 2007
Phospholipid transfer protein in hemodialysis patients
Axel Schlitt, Gunnar H Heine, Xian-Cheng Jiang, et al.
Shock (Augusta, Ga.)
|
January 24, 2012
Hemodynamic effects of intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock: the prospective, randomized IABP shock trial
Roland Prondzinsky, Susanne Unverzagt, Martin Russ, et al.
Toxins
|
November 10, 2011
Staphylococcus aureus α-toxin triggers the synthesis of B-cell lymphoma 3 by human platelets
Sebastian Schubert, Hansjörg Schwertz, Andrew S Weyrich, et al.
European Journal of Heart Failure
|
October 3, 2024
Multicentre, randomized, double-blind, prospective study on the effects of ImmunoAdSorptiOn on cardiac function in patients with Dilated CardioMyopathy (IASO-DCM): Rationale and design
Marcus Dörr, Michael Böhm, Erland Erdmann, et al.
Biochimica Et Biophysica Acta
|
October 19, 2006
Proteome analysis of myocardial tissue following ischemia and reperfusion--effects of complement inhibition
Michael Buerke, Hansjörg Schwertz, Tina Längin, et al.
American Heart Journal
|
September 29, 2009
Predictors of 30-day mortality in patients with refractory cardiogenic shock following acute myocardial infarction despite a patent infarct artery
Jason N Katz, Amanda L Stebbins, John H Alexander, et al.
Critical Care Medicine
|
September 26, 2007
Hemodynamic improvement following levosimendan treatment in patients with acute myocardial infarction and cardiogenic shock
Martin A Russ, Roland Prondzinsky, Arnd Christoph, et al.
Page
of 25
Search research articles
Search
Showing results (191-200 of 249) with videos related to
Sort By:
Page
of 25
Journal of Lipid Research
|
November 13, 2008
PLTP activity is a risk factor for subsequent cardiovascular events in CAD patients under statin therapy: the AtheroGene study
Axel Schlitt, Stefan Blankenberg, Christoph Bickel, et al.
International Journal of Cardiology
|
May 13, 2015
Prognostic impact of established and novel renal function biomarkers in myocardial infarction with cardiogenic shock: A biomarker substudy of the IABP-SHOCK II-trial
Georg Fuernau, Christian Poenisch, Ingo Eitel, et al.
Biomedizinische Technik. Biomedical Engineering
|
August 19, 2006
Analysis of complex physiological systems by information flow: a time scale-specific complexity assessment
Dirk Hoyer, Birgit Frank, Bernd Pompe, et al.
American Journal of Nephrology
|
February 20, 2007
Phospholipid transfer protein in hemodialysis patients
Axel Schlitt, Gunnar H Heine, Xian-Cheng Jiang, et al.
Shock (Augusta, Ga.)
|
January 24, 2012
Hemodynamic effects of intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock: the prospective, randomized IABP shock trial
Roland Prondzinsky, Susanne Unverzagt, Martin Russ, et al.
Toxins
|
November 10, 2011
Staphylococcus aureus α-toxin triggers the synthesis of B-cell lymphoma 3 by human platelets
Sebastian Schubert, Hansjörg Schwertz, Andrew S Weyrich, et al.
European Journal of Heart Failure
|
October 3, 2024
Multicentre, randomized, double-blind, prospective study on the effects of ImmunoAdSorptiOn on cardiac function in patients with Dilated CardioMyopathy (IASO-DCM): Rationale and design
Marcus Dörr, Michael Böhm, Erland Erdmann, et al.
Biochimica Et Biophysica Acta
|
October 19, 2006
Proteome analysis of myocardial tissue following ischemia and reperfusion--effects of complement inhibition
Michael Buerke, Hansjörg Schwertz, Tina Längin, et al.
American Heart Journal
|
September 29, 2009
Predictors of 30-day mortality in patients with refractory cardiogenic shock following acute myocardial infarction despite a patent infarct artery
Jason N Katz, Amanda L Stebbins, John H Alexander, et al.
Critical Care Medicine
|
September 26, 2007
Hemodynamic improvement following levosimendan treatment in patients with acute myocardial infarction and cardiogenic shock
Martin A Russ, Roland Prondzinsky, Arnd Christoph, et al.
Page
of 25